Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2025-12-25 @ 8:03 PM
Study NCT ID:
NCT03405935
Status:
COMPLETED
Last Update Posted:
2020-12-01
First Post:
2018-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-12
First Submit QC Date:
None
Study First Post Date:
2018-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-11-18
Results First Submit QC Date:
None
Results First Post Date:
2019-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-06
Last Update Post Date:
2020-12-01
Last Update Post Date Type:
ACTUAL